AutoImmune Incorporated

AutoImmune Inc. is a biopharmaceutical company developing a new class of orally administered pharmaceutical productsfor the treatment of autoimmune and other cell-mediated inflammatory diseases and conditions. At the start of 1999 the Company was conducting clinical trials for the following products: Colloral(R), for the treatment of rheumatoid arthritis, and AI 502, for the treatment of chronic transplant rejection. A third product, AI 401, for the treatment of Type 1 diabetes, is in Phase II clinical trials supported by Eli Lilly and Company ("Lilly") and the National Institutes of Health ("NIH"). The Company believes, based on preclinical and clinical data, that its proprietary approach to therapy can induce tissue-specific immunosuppression without toxicity or significant side effects. Additional clinical and commercial advantages of this approach include the ability to administer products orally (the preferred method of treating chronic diseases) and the potential for application to a variety of inflammatory diseases and conditions.

Contact Details: 1199 Madia Street Pasadena CA 91103 United States of America Tel: 626 792 1235 Fax: 626 792 1236 Email: WWW: www.autoimmuneinc.com/

Loading...

Recent Publications by AutoImmune Incorporated:
HLA-class I markers and multiple sclerosis susceptibility in the Italian population. Previous studies reported an association with multiple sclerosis (MS) of...	13th November, 2009	Department of Medical Sciences and Interdisciplinary Research Center of	Genes Immun. 2009 Nov 12. DOI Direct Link
A comprehensive evaluation of serum autoantibodies in primary biliary cirrhosis. In primary biliary cirrhosis (PBC) serum markers other than...	10th November, 2009	Center for Autoimmune Diseases Sheba Medical Center, Israel; Department of	J Autoimmun. 2009 Nov 6. DOI Direct Link
HLA class II polymorphism in Latin American patients with multiple sclerosis. OBJECTIVE: To identify HLA-DRB1 alleles contributing to susceptibility to...	10th November, 2009	Center for Autoimmune Diseases Research (CREA), School of Medicine and	Autoimmun Rev. 2009 Nov 4. DOI Direct Link
Inflammatory bowel disease: adverse effect of isotretinoin. OBJECTIVE: To identify HLA-DRB1 alleles contributing to susceptibility to...	7th November, 2009	Center for Autoimmune Diseases, Sheba Medical Center Tel-Hashomer and	Isr Med Assoc J. 2009 Aug;11(8):505-6.
CsA exposure is associated with acute GVHD and relapse in children after SCT. CsA is commonly used after haematological SCT (HSCT) as GVHD prophylaxis....	3rd November, 2009	Department of Paediatrics, Division of Immunology, Haematology, Oncology	Bone Marrow Transplant. 2009 Nov 2. DOI Direct Link
→View more AutoImmune Incorporated research publications.

BioNews Results for AutoImmune Incorporated:
Record Number of New Medicines in Development for Women	Pharma Live:  Nov 15 2009 7:05PM Matching: autoimmune
New market research report on inflammation drugs	News-Medical.Net:  Nov 13 2009 2:29PM Matching: autoimmune
Chemokine-Like Receptor-1 Expression by Central Nervous System-Infiltrating Leukocytes and Involvement in a Model of Autoimmune Demyelinating Disease	MDLinx:  Nov 13 2009 11:04AM Matching: autoimmune
Reportlinker Adds Autoimmune and Inflammation Inflammation	Montana's News Station:  Nov 12 2009 7:30PM Matching: autoimmune
Reportlinker Adds Autoimmune and Inflammation Inflammation	KSLA:  Nov 12 2009 8:41PM Matching: autoimmune
Promote your company here: BioNewsCast - Press Release Distribution	→View more AutoImmune Incorporated news.

AutoImmune Incorporated Patents:
US Patent No.	Title
6703361	Method of treating or preventing Type 1 diabetes by oral administration of insulin
5807993	HP-8 autoantigen
5788968	Methods and compositions for suppressing allograft rejection in mammals
5783188	Method of treating rheumatoid arthritis with type collagen peptide fragments containing repeating sequences
5763396	Method of treating or preventing type 1 diabetes by oral administration of insulin
→View more AutoImmune Incorporated patents.

AutoImmune Incorporated (AIMM) Financial information Links from Barchart
AIMM Quote from from Barchart.com
AIMM Chart from from Barchart.com
AIMM Profile from from Barchart.com
AIMM Opinion from from Barchart.com
→View more AutoImmune Incorporated finance information.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 221 individuals from AutoImmune Incorporated using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 977 times since April 2007, the link to the organisation's website has been followed 172 times

Recent Search Terms used to find this page: Autoimmunity companies | Euro-Phospholipid project | .

Search for more companies in Pasadena

Search for more companies in CA

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for AutoImmune Incorporated